Prices delayed by at least 15 minutes | Print


Indivior PLC (INDV)

ORD USD0.50
Sell: 1618p|Buy: 1620p|Change: 15.00 (0.94%)

Open 

1625p


Previous close 

1604p


Trade high 

1625p


Volume 

55,324


Year high 

1,938.00p


Year low 

1,125.00p


Dividend yield 

-


Market capitalisation 

£2.20 bn


P/E ratio 

2,041.96


ISIN 

GB00BN4HT335


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Share price

Performance 18/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Indivior PLC- 0.99
FTSE 250- 0.14
More...

Company profile

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
19/03/202401:40:53161910161.90
19/03/202401:40:05162021340.20
19/03/202401:40:05162025405.00
19/03/202401:40:05162025405.00
19/03/202401:40:05162059955.80

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.